SCHEMBL3784367

SCHEMBL3784367

Fc1ccc(-c2nnc3nc(Nc4ccccc4)ncc3n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 6/20 0.51
CYP1A2 P05177 6/20 0.51
MAPK1 P28482 4/20 0.47
CYP3A4 P08684 3/20 0.47
TSHR P16473 3/20 0.47
CYP2C19 P33261 3/20 0.47
CLK4 Q9HAZ1 2/20 0.47
CASP1 P29466 2/20 0.47
CASP7 P55210 2/20 0.47
HIF1A Q16665 2/20 0.47
CYP2C9 P11712 2/20 0.47
LMNA P02545 1/20 0.47
ABCG2 Q9UNQ0 2/20 0.46
AURKA O14965 4/20 0.46
CDK2 P24941 2/20 0.46
GSK3A P49840 2/20 0.46
GSK3B P49841 2/20 0.46
PLK4 O00444 1/20 0.46
PDPK1 O15530 1/20 0.46
JAK2 O60674 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3783305 0.82 MEN1 (0.49) USP2MAPK1TSHRCASP1CASP7
SCHEMBL3793746 0.81 ADORA1 (0.35) USP2CYP1A2MAPK1CYP3A4TSHR
SCHEMBL3787718 0.78 MEN1 (0.46) USP2CYP1A2MAPK1CYP3A4TSHR
SCHEMBL3782842 0.78 ALDH1A1 (0.51) USP2CYP1A2MAPK1CYP3A4TSHR
SCHEMBL3785163 0.78 KCNH3 (0.40) MAPK1LMNARPS6KB1MAPK8MAPK9
SCHEMBL3789583 0.74 MERTK (0.49) USP2CYP1A2TSHRCASP1CASP7
SCHEMBL3787698 0.74 PDE5A (0.46) LMNAMAPK8MAPK9KMT2AKDM4E
SCHEMBL3777980 0.74 ADORA1 (0.43) MAP4K4MEN1KMT2AKDM4EALDH1A1
SCHEMBL3782859 0.73 KCNH3 (0.47) CDK2KCNH3ADORA2BADORA1
SCHEMBL13286144 0.69 PTGS2 (0.47) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010083645-A1 PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF SHANGHAI TARGETDRUG CO., LTD (CN) 2010-07-29 WO disclosed